179 related articles for article (PubMed ID: 37973705)
1. Inhibitory effect of trans-tiliroside on very low-density lipoprotein secretion in HepG2 cells and mouse liver.
Nagatomo A; Kohno M; Kawakami H; Manse Y; Morikawa T
J Nat Med; 2024 Jan; 78(1):180-190. PubMed ID: 37973705
[TBL] [Abstract][Full Text] [Related]
2. Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein.
Craig WY; Nutik R; Cooper AD
J Biol Chem; 1988 Sep; 263(27):13880-90. PubMed ID: 2843542
[TBL] [Abstract][Full Text] [Related]
3. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2).
Arrol S; Mackness MI; Durrington PN
Atherosclerosis; 2000 Jun; 150(2):255-64. PubMed ID: 10856517
[TBL] [Abstract][Full Text] [Related]
4. Very low and low density lipoprotein synthesis and secretion by the human hepatoma cell line Hep-G2: effects of free fatty acid.
Ellsworth JL; Erickson SK; Cooper AD
J Lipid Res; 1986 Aug; 27(8):858-74. PubMed ID: 3021884
[TBL] [Abstract][Full Text] [Related]
5. Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms.
Wu X; Sakata N; Dixon J; Ginsberg HN
J Lipid Res; 1994 Jul; 35(7):1200-10. PubMed ID: 7964181
[TBL] [Abstract][Full Text] [Related]
6. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice.
Wang N; Arai T; Ji Y; Rinninger F; Tall AR
J Biol Chem; 1998 Dec; 273(49):32920-6. PubMed ID: 9830042
[TBL] [Abstract][Full Text] [Related]
7. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
[TBL] [Abstract][Full Text] [Related]
8. Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2.
Irshad Z; Chmel N; Adya R; Zammit VA
J Lipid Res; 2019 Jan; 60(1):111-120. PubMed ID: 30397187
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and secretion of VLDL by rat hepatocytes--modulation by cholesterol and phospholipids.
Kumar NS; Abraham R; Kumar GS; Sudhakaran PR; Kurup PA
Indian J Biochem Biophys; 1992 Oct; 29(5):438-41. PubMed ID: 1289236
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model.
Taghibiglou C; Carpentier A; Van Iderstine SC; Chen B; Rudy D; Aiton A; Lewis GF; Adeli K
J Biol Chem; 2000 Mar; 275(12):8416-25. PubMed ID: 10722675
[TBL] [Abstract][Full Text] [Related]
11. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
[No Abstract] [Full Text] [Related]
12. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B.
Tietge UJ; Bakillah A; Maugeais C; Tsukamoto K; Hussain M; Rader DJ
J Lipid Res; 1999 Nov; 40(11):2134-9. PubMed ID: 10553017
[TBL] [Abstract][Full Text] [Related]
13. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
[TBL] [Abstract][Full Text] [Related]
14. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
Dashti N; Wolfbauer G
Biochim Biophys Acta; 1986 Feb; 875(3):473-86. PubMed ID: 3004589
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
Cianflone K; Avramoglu RK; Sawyez C; Huff MW
Atherosclerosis; 1996 Feb; 120(1-2):101-14. PubMed ID: 8645351
[TBL] [Abstract][Full Text] [Related]
16. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
17. Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride-VLDL Secretion via ApoB Degradation.
Lin H; Wang L; Liu Z; Long K; Kong M; Ye D; Chen X; Wang K; Wu KK; Fan M; Song E; Wang C; Hoo RL; Hui X; Hallenborg P; Piao H; Xu A; Cheng KK
Adv Sci (Weinh); 2022 Jul; 9(20):e2200742. PubMed ID: 35524581
[TBL] [Abstract][Full Text] [Related]
18. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
[TBL] [Abstract][Full Text] [Related]
19. Assembly and secretion of VLDL in nondifferentiated Caco-2 cells stably transfected with human recombinant ApoB48 cDNA.
Luchoomun J; Zhou Z; Bakillah A; Jamil H; Hussain MM
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2955-63. PubMed ID: 9409282
[TBL] [Abstract][Full Text] [Related]
20. Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans.
Reyes-Soffer G; Moon B; Hernandez-Ono A; Dionizovik-Dimanovski M; Jimenez J; Obunike J; Thomas T; Ngai C; Fontanez N; Donovan DS; Karmally W; Holleran S; Ramakrishnan R; Mittleman RS; Ginsberg HN
Sci Transl Med; 2016 Jan; 8(323):323ra12. PubMed ID: 26819195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
